Critical Review: Enovis (NYSE:ENOV) and Advanced Biomedical Technologies (OTCMKTS:ABMT)
Critical Review: Enovis (NYSE:ENOV) and Advanced Biomedical Technologies (OTCMKTS:ABMT)
Enovis (NYSE:ENOV – Get Rating) and Advanced Biomedical Technologies (OTCMKTS:ABMT – Get Rating) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their earnings, dividends, valuation, analyst recommendations, institutional ownership, risk and profitability.
Enovis(NYSE：ENOV-GET Rating)和Advanced Biomedical Technologies(OTCMKTS：ABMT-GET Rating)都是医疗公司，但哪一家是更好的投资？我们将根据两家公司的收益、股息、估值、分析师建议、机构持股、风险和盈利能力等方面的实力进行比较。
Analyst Recommendations
分析师建议
This is a breakdown of current recommendations for Enovis and Advanced Biomedical Technologies, as reported by MarketBeat.
据MarketBeat报道，这是对Enovis和先进生物医学技术的当前建议的细分。
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Enovis | 0 | 2 | 1 | 0 | 2.33 |
| Advanced Biomedical Technologies | 0 | 0 | 0 | 0 | N/A |
| 销售评级 | 保持评级 | 购买评级 | 强劲的买入评级 | 评级分数 | |
| 伊诺维斯 | 0 | 2 | 1 | 0 | 2.33 |
| 先进生物医学技术 | 0 | 0 | 0 | 0 | 不适用 |
Enovis currently has a consensus price target of $67.00, suggesting a potential upside of 16.12%. Given Enovis' higher possible upside, research analysts clearly believe Enovis is more favorable than Advanced Biomedical Technologies.
Enovis目前的普遍目标价为67.00美元，这意味着潜在的上涨幅度为16.12%。考虑到Enovis更有可能的上行空间，研究分析师显然认为Enovis比Advanced Biomedical Technologies更有利。
Profitability
盈利能力
| Net Margins | Return on Equity | Return on Assets | |
| Enovis | 1.77% | 6.35% | 3.57% |
| Advanced Biomedical Technologies | N/A | N/A | N/A |
| 净利润率 | 股本回报率 | 资产回报率 | |
| 伊诺维斯 | 1.77% | 6.35% | 3.57% |
| 先进生物医学技术 | 不适用 | 不适用 | 不适用 |
Risk and Volatility
风险和波动性
Enovis has a beta of 2.18, meaning that its stock price is 118% more volatile than the S&P 500. Comparatively, Advanced Biomedical Technologies has a beta of -1, meaning that its stock price is 200% less volatile than the S&P 500.
Enovis的贝塔系数为2.18，这意味着其股价的波动性比标准普尔500指数高118%。相比之下，Advanced Biomedical Technologies的贝塔系数为-1，这意味着其股价的波动性比标准普尔500指数低200%。
Earnings & Valuation
收益与估值
This table compares Enovis and Advanced Biomedical Technologies' top-line revenue, earnings per share and valuation.
此表比较了Enovis和Advanced Biomedical Technologies的营收、每股收益和估值。
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Enovis | $3.85 billion | 0.81 | $71.66 million | $1.32 | 43.71 |
| Advanced Biomedical Technologies | $120,000.00 | 35.88 | -$670,000.00 | N/A | N/A |
| 总收入 | 价格/销售额比 | 净收入 | 每股收益 | 市盈率 | |
| 伊诺维斯 | 38.5亿美元 | 0.81 | 7166万美元 | $1.32 | 43.71 |
| 先进生物医学技术 | $120,000.00 | 35.88 | -$670,000.00 | 不适用 | 不适用 |
Enovis has higher revenue and earnings than Advanced Biomedical Technologies.
Enovis的收入和收益高于Advanced Biomedical Technologies。
Summary
摘要
Enovis beats Advanced Biomedical Technologies on 8 of the 9 factors compared between the two stocks.
在两只股票比较的9个因素中，Enovis有8个击败了Advanced Biomedical Technologies。
About Enovis
关于Enovis
(Get Rating)
(获取评级)
Enovis Corporation operates as a medical technology company worldwide. It develops, manufactures, and distributes medical device products used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events, and sports related injuries. It offers rigid and soft orthopedic bracings, hot and cold therapy products, bone growth stimulators, vascular therapy systems and compression garments, therapeutic shoes and inserts, electrical stimulators used for pain management, and physical therapy products; and a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger. Enovis Corporation sells its products through independent distributors, such as healthcare professionals, consumer retail stores, and pharmacies; and directly under the DJO brand. The company was formerly known as Colfax Corporation. Enovis Corporation is headquartered in Wilmington, Delaware.
Enovis公司是一家全球性的医疗技术公司。该公司开发、制造和分销医疗器械产品，供整形外科专家、外科医生、初级保健医生、疼痛管理专家、物理治疗师、足科医生、脊椎按摩师、运动训练师和其他医疗保健专业人员使用，以治疗因退行性疾病、畸形、创伤事件和运动相关伤害而导致的肌肉骨骼疾病患者。它提供坚硬和柔软的矫形支撑、冷热治疗产品、骨生长刺激器、血管治疗系统和加压服装、治疗鞋和衬垫、用于疼痛管理的电刺激器和物理治疗产品；以及一套用于髋关节、膝部、肩部、肘部、足部、脚踝和手指的重建关节产品。Enovis Corporation通过医疗保健专业人员、消费者零售店和药店等独立分销商销售其产品，并直接以DJO品牌销售。该公司的前身是科尔法克斯公司。Enovis公司总部设在特拉华州威尔明顿。
About Advanced Biomedical Technologies
关于先进的生物医学技术
(Get Rating)
(获取评级)
Advanced Biomedical Technologies, Inc., a development stage company, designs, develops, manufactures, and markets biomaterial internal fixation devices. It offers polymer osteosynthesis devices, such as surgical screws, binding wires, rods, and related medical devices for the treatment of orthopedic trauma, sports-related medical treatment, cartilage repair, and related treatments, as well as for reconstructive dental procedures. The company was formerly known as Geostar Mineral Corporation and changed its name to Advanced Biomedical Technologies, Inc. in March 2009. Advanced Biomedical Technologies, Inc. was founded in 2002 and is based in New York, New York.
高级生物医学技术公司是一家处于发展阶段的公司，设计、开发、制造和销售生物材料内固定设备。它提供聚合物骨接合设备，如外科螺丝、捆绑钢丝、棒和相关医疗设备，用于治疗骨科创伤、与运动相关的医疗、软骨修复和相关治疗，以及重建牙科程序。该公司前身为Geostar矿业公司，并于2009年3月更名为Advanced Biomedical Technologies，Inc.。先进生物医学技术公司成立于2002年，总部设在纽约。
Receive News & Ratings for Enovis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Enovis and related companies with MarketBeat.com's FREE daily email newsletter.
接受《Enovis Daily》的新闻和评级-在下面输入您的电子邮件地址，通过MarketBeat.com的免费每日电子邮件时事通讯接收对Enovis和相关公司的最新新闻和分析师评级的每日简要摘要。